Bilateral retinal vein occlusion associated with 5,10- methylenetetrahydrofolate reductase mutation

American Journal of Ophthalmology

Volumn 124, Issue 6, 1997, Pages 840-841

  Loewenstein, A ^a   Winder, A ^a   Goldstein, M ^a   Lazar, M ^a   Eldor, A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS;

EID: 0030862371     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71703-9     Document Type: Article

References (5)

1. R Clarke L Daly K Robinson Hyperhomocystinemia: an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
2. M den Heijer T Koster HJ Blom Hyperhomocystinemia as a risk factor for deep vein thrombosis N Engl J Med 334 1996 759 762
3. LAJ Kluijtmans van den Heuvel LPWJ GHJ Boers Molecular genetic analysis in mild hyperhomocystinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease Am J Hum Genet 58 1996 35 41
4. A Vine MM Samama The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions Surv Ophthalmol 37 1993 283 292
5. DG Franken GHJ Boers HJ Blom Treatment of mild hyperhomocystinemia in vascular disease patients Arterioscler Thromb Vasc Biol 14 1994 465 470